上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1147Please respect copyright.PENANAlhSW5hCU9u
1147Please respect copyright.PENANAHkJzcRwXAW
上集:https://www.penana.com/article/4711251147Please respect copyright.PENANADvLU3oqnSc
1147Please respect copyright.PENANAZAJNZTH7Ip
1147Please respect copyright.PENANAotAoEcAJnm
1147Please respect copyright.PENANA8VzPVKKSfJ
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1147Please respect copyright.PENANA1PRO9m1HCn
1147Please respect copyright.PENANASJipzt67Ua
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1147Please respect copyright.PENANABDFWDli0uT
1147Please respect copyright.PENANAaCUIveQgPW
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1147Please respect copyright.PENANAWuymcUEFDo
1147Please respect copyright.PENANANpQkm8HUrf
1147Please respect copyright.PENANA0ZiMKfUkH7
1147Please respect copyright.PENANASE26ZelfhW
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1147Please respect copyright.PENANAevEi8YWUfe
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1147Please respect copyright.PENANAI2KNIjfzht
1147Please respect copyright.PENANAHvAMkXiIf1
忘記甚麼是Neoantigen的話,可重溫上一集。1147Please respect copyright.PENANAqVDKw3CuSU
1147Please respect copyright.PENANACkaUWGfplS
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1147Please respect copyright.PENANAnXfbe7GTpC
1147Please respect copyright.PENANAnE3eaUj5Ca
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1147Please respect copyright.PENANAzEpUovePlN
1147Please respect copyright.PENANAXwDgcaYQ8S
1147Please respect copyright.PENANALE3xUP0Is9
1147Please respect copyright.PENANApHBrwG81Rv
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1147Please respect copyright.PENANA1xpU2Ndtk0
1147Please respect copyright.PENANABobC712d8E
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1147Please respect copyright.PENANA26iVwkJMiO
1147Please respect copyright.PENANAk9JSsa0rQM
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1147Please respect copyright.PENANAErmsrP7e44
1147Please respect copyright.PENANAxgcWJHo3c5
1147Please respect copyright.PENANAbUvdKf4HVn
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1147Please respect copyright.PENANAprMJCZ4FBc
1147Please respect copyright.PENANAwJamuTSk3q
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1147Please respect copyright.PENANA7lD3zpjclA
1147Please respect copyright.PENANAvRz7OEicjl
1147Please respect copyright.PENANAifPNZ9D1X6
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1147Please respect copyright.PENANAKh6bJlmxwn
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1147Please respect copyright.PENANAZuKbTj8SEv
1147Please respect copyright.PENANAlyHC9lDoqF
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1147Please respect copyright.PENANAksQLR0Xosn
1147Please respect copyright.PENANA85bRNJccah
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1147Please respect copyright.PENANAm8oHsGkzg3
1147Please respect copyright.PENANA9T7vRA6Gfy
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1147Please respect copyright.PENANATqSLQxK6Yn
1147Please respect copyright.PENANAVojZr51tJw
1147Please respect copyright.PENANA69kx3LZ05c
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1147Please respect copyright.PENANA3e6ugqFXX2
1147Please respect copyright.PENANA1dozCrgowu
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1147Please respect copyright.PENANA5voyRNLNTM
1147Please respect copyright.PENANAfYvkrI6CJq
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1147Please respect copyright.PENANA3QYA6VpYrg
1147Please respect copyright.PENANATWCLc0jcwn
Link:1147Please respect copyright.PENANAQ7Q5tgFY8Z
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1147Please respect copyright.PENANAS1n0ltC9nA
1147Please respect copyright.PENANAJiQvH1aJjs
1147Please respect copyright.PENANAVYV1hNTflO
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1147Please respect copyright.PENANApAsSNix6Ie